1

2
Noriko Oku legal representative, Chikako Oku legal representative, Tomohito Oku legal representative, Hiroshi Kayakiri, Yoshito Abe, Hitoshi Hamashima, Hitoshi Sawada, Naoki Ishibashi, Hiroyuki Setoi, Noritsugu Yamasaki, Takafumi Imoto, Takahiro Hiramura: Imidazole compounds and medicinal use thereof. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, June 13, 2006: US07060721 (39 worldwide citation)

Imidazole compounds represented by general formula (I): wherein each symbol is as defined in the specification, and salts thereof, and a pharmaceutical composition containing same are provided. These compounds are useful in treating the diseases curable based on a hypoglycemic action, and the diseas ...


3

4
Teruo Oku, Hiroshi Kayakiri, Shigeki Satoh, Yoshito Abe, Yuki Sawada, Takayuki Inoue, Hirokazu Tanaka: Bradykinin antagonist quinolines. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, October 8, 1996: US05563162 (33 worldwide citation)

This invention relates to new heterocyclic compounds and pharmaceutically acceptable salts thereof. More particularly, this invention relates to new heterocyclic compounds and salts thereof which display bradykinin antagonist activity, to processes for preparing these compounds, to a pharmaceutical ...


5

6

7
Teruo Oku, Hiroyuki Setoi, Hiroshi Kayakiri, Shigeki Satoh, Takayuki Inoue, Yuki Sawada, Akio Kuroda, Hirokazu Tanaka: Angiotenin II antagonizing heterocyclic compounds. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt, October 11, 1994: US05354759 (24 worldwide citation)

This invention related to compounds of the formula ##STR1## wherein the radicals are as defined in the claims. The compounds are angiotensin II antagonists useful in treating hypertension, etc.


8
Teruo Oku, Hiroshi Kayakiri, Shigeki Satoh, Yoshito Abe, Yuki Sawada, Takayuki Inoue, Hirokazu Tanaka: Heterocyclic compounds. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, January 13, 1998: US05708173 (24 worldwide citation)

A compound of the formula: ##STR1## or its salt is prepared by reacting a compound of the formula: ##STR2## with a compound of the formula: ##STR3## Wherein the variables are all defined in claim 1.


9

10